Aptus Capital Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Aptus Capital Advisors's IDXX Position: Q2 2026 in Review
Aptus Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 1% in Q2 2026, selling an estimated $57.8K and leaving 9,994 shares worth $5.26M. The position accounts for 0.04% of the portfolio, ranked #354.
Aptus Capital Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.27M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Aptus Capital Advisors held 9,994 shares of Idexx Laboratories worth $5.26M as of Q2 2026.
- Aptus Capital Advisors sold 103 Idexx Laboratories shares in Q2 2026, an estimated $57.8K.
- Idexx Laboratories made up 0.04% of Aptus Capital Advisors's portfolio in Q2 2026, its #354 holding.
- Aptus Capital Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
- Aptus Capital Advisors's Idexx Laboratories position peaked at $8.27M in Q4 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.